
Loading, please wait...

Loading, please wait...

The COVID-19 pandemic significantly altered how patients access medical services globally. Recent research highlights a concerning shift in dengue healthcare seeking behavior during and after the outbreak. While the pandemic overwhelmed health systems, it also created a "smokescreen" effect. Clinicians often misattributed febrile illnesses to COVID-19. Consequently, this led to critical delays in dengue diagnosis and management.
A sentinel surveillance study in Puerto Rico compared data from 2014–2020 to 2020–2023. Researchers found that the median age of patients seeking care for dengue increased during the latter period. Furthermore, the duration of illness before presenting to a healthcare facility shifted significantly. This change reflected how communities perceived risk and accessible care. Therefore, these delays can lead to a higher risk of severe complications. Such complications include plasma leakage and dangerous hemorrhagic manifestations.
In India, where dengue is hyper-endemic, clinicians observed similar trends. Many patients avoided hospitals due to fear of COVID-19 infection. Others found that diagnostic resources were redirected to pandemic needs. Therefore, clinicians must remain vigilant during monsoon seasons. Early identification of "warning signs" is essential for patient survival. These signs include persistent vomiting, abdominal pain, and mucosal bleeding. Additionally, the National Guidelines for 2023 emphasize that early fluid management is the cornerstone of treatment. Because symptoms overlap with other viral infections, laboratory confirmation is vital. Providers should use NS1 antigen or IgM ELISA for timely intervention.
The pandemic demonstrated that health-seeking patterns are fragile. By understanding these shifts, providers can better educate patients on when to seek immediate care. Continuous surveillance and public awareness are necessary. These efforts ensure that seasonal dengue outbreaks do not result in preventable deaths due to delayed presentation.
The overlap of symptoms like fever and body ache often led to misdiagnosis. Additionally, many patients delayed seeking care due to lockdowns or fear of contracting COVID-19 in hospitals.
Patients should seek urgent medical attention if they experience severe abdominal pain, persistent vomiting, rapid breathing, or bleeding gums, as these indicate a progression toward severe dengue.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Exploring how the pandemic influenced delays in dengue care and what this means for managing future outbreaks in endemic regions like India....
8 months ago

A breakthrough study evaluated H5N1 transmission efficiency across mammalian isolates. Researchers discovered that human-derived D1.1 harboring the PB2 D701N mutation spread efficiently in ferrets, unlike strains carrying PB2 E627K. This finding highlights critical genetic markers for zoonotic surveillance.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today